Delivery Order SPE2DB25D3020-SPE2DB25FWKPL
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,719.34 by the Defense Logistics Agency on July 31, 2025, for the supply of Prevymis 480 mg tablets in packages of seven units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 21, 2025, and represents performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,158.40 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order valued at $34,237.95 from the Defense Logistics Agency's Medical Supply Chain on August 28, 2025. This firm fixed-price delivery order, designated as a child contract under a larger indefinite delivery vehicle, is set to conclude by August 29, 2025, and will be performed at the company's corporate office location in Conshohocken, PA. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $16,771.92 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 11, 2025, represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,002.78 on August 6, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, with an ultimate completion date of August 7, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,636.04 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025. This firm fixed price delivery order, which represents a child contract under a larger indefinite delivery vehicle, is non-competitive and carries an ultimate completion date of September 11, 2025. The award leverages AmerisourceBergen's extensive federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,543.68 by the Defense Logistics Agency's Medical Supply Chain on September 9, 2025. This contract, which is a child order under a larger indefinite delivery vehicle, involves the firm fixed price delivery of pharmaceutical products and medical supplies to support federal medical procurement needs. The award was competitively procured with no...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $1,582.18 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitively competed delivery order valued at $41,660.52 by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. The delivery order, which is classified as a child contract under a larger Indefinite Delivery Contract vehicle, carries a firm fixed price structure and is scheduled for ultimate completion on September 9, 2025. This award involves no...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,020.06 on September 8, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price, non-competitive delivery order is due for completion by September 9, 2025, and represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract utilizes no set-aside...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWKPLDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 15, 2025, for the supply of Prevymis 480 mg tablets in quantities of 7 per unit. This firm fixed-price delivery order, valued at $4,719.34, represents a non-competitive award executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026. The contract is scheduled for completion by October 6, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order exemplifies AmerisourceBergen's role as a critical vendor within the Defense Health Agency's pharmaceutical supply chain, providing specialized pharmaceutical products to support military healthcare programs. As a child contract under the larger SPE2DX prime vendor agreement, this award reflects the company's established capability to deliver brand-name medications and medical supplies through a competitive, firm fixed-price contracting mechanism. The DLA's Pharmaceutical Prime Vendor program, of which this contract vehicle is a component, enables flexible procurement of pharmaceutical commodities and medical supplies across multiple therapeutic domains to serve military, veteran, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 9/15/25 |